Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection
Standard
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection. / Hengst, Julia; Klein, Andreas L; Lunemann, Sebastian; Deterding, Katja; Hardtke, Svenja; Falk, Christine S; Manns, Michael P; Cornberg, Markus; Schlaphoff, Verena; Wedemeyer, Heiner.
in: J VIRAL HEPATITIS, Jahrgang 26, Nr. 4, 04.2019, S. 466-475.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection
AU - Hengst, Julia
AU - Klein, Andreas L
AU - Lunemann, Sebastian
AU - Deterding, Katja
AU - Hardtke, Svenja
AU - Falk, Christine S
AU - Manns, Michael P
AU - Cornberg, Markus
AU - Schlaphoff, Verena
AU - Wedemeyer, Heiner
N1 - © 2018 John Wiley & Sons Ltd.
PY - 2019/4
Y1 - 2019/4
N2 - The natural course of acute Hepatitis C Virus (aHCV) infection is highly heterogeneous, and only few biomarkers have been identified to reliably predict the outcome of infection. We analysed a large panel of soluble inflammatory mediators, immune cell frequencies and phenotypes using peripheral blood samples from 26 patients with symptomatic aHCV infection from a controlled randomized clinical trial (ISRCTN88729946, www.isrctn.com). We found that patients with a spontaneous early HCV control demonstrated a distinct expression pattern of various soluble immune mediators including IFNα and IL-16. Immune cell phenotype and frequency differed between patients who cleared the viral infection early (n=13) and those who remained HCV RNA positive after 12 weeks of observation (n=13) with a reduced ratio of CD4+ T cells to NK cells in the non-early clearer. Further, correlation analyses of 50 cytokines and chemokines revealed more positive correlations in between the distinct cytokines, especially for IFNα and IL-16, and between the cytokines and HCV RNA levels in spontaneous early clearer patients. Beyond that, in vitro stimulation of CD4+ T cells with IL-16 reduced the susceptibility of these cells to killing by IFNα-activated NK cells. These data indicate that the immune cell composition and cytokine pattern varies considerably in patients with symptomatic aHCV infection. NK cell-mediated killing of CD4+ T cells might affect early control of HCV infection.
AB - The natural course of acute Hepatitis C Virus (aHCV) infection is highly heterogeneous, and only few biomarkers have been identified to reliably predict the outcome of infection. We analysed a large panel of soluble inflammatory mediators, immune cell frequencies and phenotypes using peripheral blood samples from 26 patients with symptomatic aHCV infection from a controlled randomized clinical trial (ISRCTN88729946, www.isrctn.com). We found that patients with a spontaneous early HCV control demonstrated a distinct expression pattern of various soluble immune mediators including IFNα and IL-16. Immune cell phenotype and frequency differed between patients who cleared the viral infection early (n=13) and those who remained HCV RNA positive after 12 weeks of observation (n=13) with a reduced ratio of CD4+ T cells to NK cells in the non-early clearer. Further, correlation analyses of 50 cytokines and chemokines revealed more positive correlations in between the distinct cytokines, especially for IFNα and IL-16, and between the cytokines and HCV RNA levels in spontaneous early clearer patients. Beyond that, in vitro stimulation of CD4+ T cells with IL-16 reduced the susceptibility of these cells to killing by IFNα-activated NK cells. These data indicate that the immune cell composition and cytokine pattern varies considerably in patients with symptomatic aHCV infection. NK cell-mediated killing of CD4+ T cells might affect early control of HCV infection.
U2 - 10.1111/jvh.13050
DO - 10.1111/jvh.13050
M3 - SCORING: Journal article
C2 - 30548086
VL - 26
SP - 466
EP - 475
JO - J VIRAL HEPATITIS
JF - J VIRAL HEPATITIS
SN - 1352-0504
IS - 4
ER -